GlaxoSmithKline CEO Witty to bow out in March 2017
0
LONDON (Reuters) - GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the British drugmaker through a series of changes since 2008 that have failed to ignite the share price.